A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapy

Current multimodality therapy consisting of surgery, chemotherapy and radiation will fail in approximately 40% of patients with pediatric sarcomas and results in substantial long-term morbidity in those who are cured. Immunotherapeutic regimens for the treatment of solid tumors typically generate an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Duncan, Brynn B., Highfill, Steven L., Qin, Haiying, Bouchkouj, Najat, Larabee, Shannon, Zhao, Peng, Woznica, Iwona, Liu, Yuxin, Li, Youhua, Wu, Wengen, Lai, Jack H., Jones, Barry, Mackall, Crystal L., Bachovchin, William W., Fry, Terry J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3852174/
https://ncbi.nlm.nih.gov/pubmed/23994886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0b013e3182a80213
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados